Chris Henry
About Chris Henry
Chris Henry serves as the Executive Director of CMC at BridgeBio, where he has been employed since 2024. He has extensive experience in process chemistry and has held various roles in prominent biotechnology companies, including Protagonist Therapeutics and Achaogen.
Current Role at BridgeBio
Chris Henry serves as the Executive Director of CMC at BridgeBio, a position he has held since 2024. In this role, he oversees the Chemistry, Manufacturing, and Controls (CMC) operations for BridgeBio and its subsidiaries, including Portal Therapeutics, Cantero Therapeutics, and CoA Therapeutics. His responsibilities include providing CMC and Drug Substance (DS) support to various subsidiaries, including Calcilytix. His leadership in CMC is pivotal for the development and manufacturing processes within the organization.
Previous Experience at BridgeBio
Before becoming Executive Director, Chris Henry held several positions at BridgeBio. He was the Senior Director of CMC from 2022 to 2023 and served as Director of CMC from 2020 to 2021. His progressive roles within the company demonstrate his expertise and commitment to advancing the company's objectives in drug development and manufacturing.
Professional Background
Chris Henry has a diverse professional background in the pharmaceutical industry. He worked at Protagonist Therapeutics as Associate Director of Process Chemistry from 2018 to 2020. Prior to that, he was employed at Achaogen in various roles, including Scientist II and Senior Scientist, from 2014 to 2016, and later as Associate Director of Process Chemistry from 2017 to 2018. His experience spans multiple aspects of drug development and process chemistry.
Education and Expertise
Chris Henry earned a Bachelor of Science degree in Chemistry and Biology from William & Mary, where he studied from 1999 to 2003. He furthered his education at UCLA, obtaining a PhD in Synthetic Organic Chemistry from 2003 to 2008. His academic background provides a strong foundation for his work in the pharmaceutical sector, particularly in chemistry and drug development.
Postdoctoral Research Experience
After completing his PhD, Chris Henry worked as a Postdoctoral Scholar at Caltech from 2008 to 2011. This experience allowed him to deepen his research skills and knowledge in chemistry, contributing to his subsequent roles in the pharmaceutical industry. His postdoctoral work is an essential part of his professional development.